Group 1 - The core viewpoint of the article highlights the significant performance of the CESHKB index, which has seen substantial increases over various time frames, indicating a strong market trend in the biotechnology sector in Hong Kong [1][2]. - The CESHKB index rose by 3.66% to 7559.76 points, with a trading volume of 12.113 billion [1]. - Over the past month, the CESHKB index has increased by 15.96%, by 28.51% over the last three months, and has risen 62.76% year-to-date [1]. Group 2 - The CESHKB index is compiled by China Securities Index Co., Ltd. and aims to reflect the overall performance of biotechnology companies listed in Hong Kong [1]. - The index is based on a reference date of December 12, 2014, with a base point of 2000.0 [1]. - The top ten holdings of the CESHKB index include companies such as CanSino Biologics (10.79%), Innovent Biologics (10.03%), and BeiGene (9.56%) [1]. Group 3 - The market composition of the CESHKB index is entirely based on the Hong Kong Stock Exchange [2]. - In terms of industry distribution, biopharmaceuticals account for 56.98%, pharmaceutical and biotechnology services for 24.70%, chemical drugs for 16.03%, and medical devices for 2.29% [2].
中华交易服务香港生物科技指数上涨3.66%，前十大权重包含药明生物等